• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善临床试验中患者的参与度——IMPACT 的原理和设计。

IMproving PArticipation of patients in Clinical Trials--rationale and design of IMPACT.

机构信息

Department of Obstetrics and Gynaecology, Academic Medical Centre, Amsterdam, The Netherlands.

出版信息

BMC Med Res Methodol. 2010 Sep 27;10:85. doi: 10.1186/1471-2288-10-85.

DOI:10.1186/1471-2288-10-85
PMID:20875119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2955658/
Abstract

BACKGROUND

One of the most commonly reported problems of randomised trials is that recruitment is usually slower than expected. Trials will cost more and take longer, thus delaying the use of the results in clinical practice, and incomplete samples imply decreased statistical power and usefulness of its results. We aim to identify barriers and facilitators for successful patient recruitment at the level of the patient, the doctor and the hospital organization as well as the organization and design of trials over a broad range of studies.

METHODS/DESIGN: We will perform two cohort studies and a case-control study in The Netherlands. The first cohort study will report on a series of multicenter trials performed in a nationwide network of clinical trials in obstetrics and gynaecology. A questionnaire will be sent to all clinicians recruiting for these trials to identify determinants--aggregated at centre level--for the recruitment rate. In a case control-study nested in this cohort we will interview patients who refused or consented participation to identify factors associated with patients' consent or refusal. In a second cohort study, we will study trials that were prospectively registered in the Netherlands Trial Register. Using a questionnaire survey we will assess whether issues on hospital organization, trial organization, planning and trial design were associated with successful recruitment, i.e. 80% of the predefined number of patients recruited within the planned time.

DISCUSSION

This study will provide insight in barriers and facilitators for successful patient recruitment in trials. The results will be used to provide recommendations and a checklist for individual trialists to identify potential pitfalls for recruitment and judge the feasibility prior to the start of the study. Identified barriers and motivators coupled to evidence-based interventions can improve recruitment of patients in clinical trials.

摘要

背景

随机试验中最常报告的问题之一是招募通常比预期的要慢。试验将花费更多的时间和成本,从而延迟其在临床实践中的应用,并且不完整的样本意味着统计效力降低,结果的实用性也降低。我们旨在确定患者、医生和医院组织层面以及试验组织和设计层面的成功招募的障碍和促进因素,涵盖广泛的研究。

方法/设计:我们将在荷兰进行两项队列研究和一项病例对照研究。第一项队列研究将报告在全国性妇产科临床试验网络中进行的一系列多中心试验。将向所有招募这些试验的临床医生发送一份问卷,以确定中心层面上影响招募率的决定因素。在这项队列研究中嵌套一项病例对照研究,我们将采访拒绝或同意参与的患者,以确定与患者同意或拒绝相关的因素。在第二项队列研究中,我们将研究在荷兰试验注册处前瞻性注册的试验。我们将使用问卷调查来评估医院组织、试验组织、规划和试验设计等问题是否与成功招募相关,即在计划时间内招募到预定患者人数的 80%。

讨论

这项研究将深入了解试验中成功招募患者的障碍和促进因素。研究结果将用于为个体试验者提供建议和清单,以确定招募的潜在陷阱,并在研究开始前判断可行性。确定障碍和激励因素,并结合基于证据的干预措施,可以提高临床试验中患者的招募率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a8/2955658/911db52c7bf0/1471-2288-10-85-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a8/2955658/911db52c7bf0/1471-2288-10-85-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a8/2955658/911db52c7bf0/1471-2288-10-85-1.jpg

相似文献

1
IMproving PArticipation of patients in Clinical Trials--rationale and design of IMPACT.改善临床试验中患者的参与度——IMPACT 的原理和设计。
BMC Med Res Methodol. 2010 Sep 27;10:85. doi: 10.1186/1471-2288-10-85.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study.随机试验的招募:试验入组与参与策略研究。STEPS研究。
Health Technol Assess. 2007 Nov;11(48):iii, ix-105. doi: 10.3310/hta11480.
5
A qualitative study of recruitment barriers, motivators, and community-based strategies for increasing clinical trials participation among rural and urban populations.一项关于招募障碍、动机以及增加农村和城市人口参与临床试验的社区策略的定性研究。
Am J Health Promot. 2015 May-Jun;29(5):332-8. doi: 10.4278/ajhp.130514-QUAL-247. Epub 2014 Mar 26.
6
The effect of survey method on survey participation: analysis of data from the Health Survey for England 2006 and the Boost Survey for London.调查方法对调查参与的影响:来自 2006 年英格兰健康调查和伦敦助推调查的数据分析。
BMC Med Res Methodol. 2010 Sep 27;10:83. doi: 10.1186/1471-2288-10-83.
7
Participation and successful patient recruitment in primary care.基层医疗中的患者参与及成功招募
J Fam Pract. 2001 Nov;50(11):976.
8
The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials.利用常规收集的电子记录进行务实的即时随机试验的机遇与挑战:两项示例试验的评估
Health Technol Assess. 2014 Jul;18(43):1-146. doi: 10.3310/hta18430.
9
Using evidence when planning for trial recruitment: An international perspective from time-poor trialists.利用证据规划临床试验招募:来自时间紧张的试验者的国际视角。
PLoS One. 2019 Dec 10;14(12):e0226081. doi: 10.1371/journal.pone.0226081. eCollection 2019.
10
A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT).一项可行性研究,旨在为一项随机对照试验的设计提供信息,以确定低分子量肝素抗凝治疗癌症相关血栓形成(ALICAT)的最具临床疗效和成本效益的疗程。
Health Technol Assess. 2015 Oct;19(83):vii-xxiii, 1-93. doi: 10.3310/hta19830.

引用本文的文献

1
Virtual visits to optimize research trial offerings to heart failure patients.虚拟问诊以优化针对心力衰竭患者的研究试验服务。
Cardiovasc Digit Health J. 2021 Nov 18;3(1):40-45. doi: 10.1016/j.cvdhj.2021.10.006. eCollection 2022 Feb.
2
Connecting the public with clinical trial options: The ResearchMatch Trials Today tool.将公众与临床试验选项相连接:今日ResearchMatch试验工具。
J Clin Transl Sci. 2018 Aug;2(4):253-257. doi: 10.1017/cts.2018.327.
3
Validation of the Russian Version of the Positive and Negative Syndrome Scale (PANSS-Ru) and Normative Data.

本文引用的文献

1
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.招募代表性不足人群参与癌症临床试验的障碍:一项系统综述。
Cancer. 2008 Jan 15;112(2):228-42. doi: 10.1002/cncr.23157.
2
Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study.随机试验的招募:试验入组与参与策略研究。STEPS研究。
Health Technol Assess. 2007 Nov;11(48):iii, ix-105. doi: 10.3310/hta11480.
3
A systematic review highlights threats to validity in studies of barriers to cancer trial participation.
阳性与阴性症状量表俄语版(PANSS-Ru)的验证及常模数据
Innov Clin Neurosci. 2018 Oct 1;15(9-10):32-48.
4
Facilitators and challenges in recruiting pregnant women to an infant obesity prevention programme delivered via telephone calls or text messages.在通过电话或短信开展的预防婴儿肥胖计划中招募孕妇的促进因素和挑战。
Trials. 2018 Sep 15;19(1):494. doi: 10.1186/s13063-018-2871-5.
5
Improving recruitment to clinical trials during pregnancy: A mixed methods investigation.提高孕期临床试验招募效果:一项混合方法研究。
Soc Sci Med. 2018 Mar;200:73-82. doi: 10.1016/j.socscimed.2018.01.014. Epub 2018 Jan 17.
6
Selection bias in clinical stroke trials depending on ability to consent.取决于同意能力的临床中风试验中的选择偏倚。
BMC Neurol. 2017 Dec 4;17(1):206. doi: 10.1186/s12883-017-0989-9.
7
Behavioural activation by mental health nurses for late-life depression in primary care: a randomized controlled trial.心理健康护士对初级保健中老年人抑郁症的行为激活:一项随机对照试验。
BMC Psychiatry. 2017 Jun 26;17(1):230. doi: 10.1186/s12888-017-1388-x.
8
Recruitment of older adults with type 2 diabetes into a community-based exercise and nutrition randomised controlled trial.招募2型糖尿病老年人参加一项基于社区的运动与营养随机对照试验。
Trials. 2016 Sep 26;17(1):467. doi: 10.1186/s13063-016-1589-5.
9
Pregnant womens' concerns when invited to a randomized trial: a qualitative case control study.受邀参加随机试验时孕妇的顾虑:一项定性病例对照研究。
BMC Pregnancy Childbirth. 2015 Sep 4;15:207. doi: 10.1186/s12884-015-0641-x.
10
Barriers and opportunities for enhancing patient recruitment and retention in clinical research: findings from an interview study in an NHS academic health science centre.提高临床研究中患者招募与留存率的障碍与机遇:来自国民保健服务体系(NHS)学术健康科学中心一项访谈研究的结果
Health Res Policy Syst. 2015 Mar 12;13:8. doi: 10.1186/1478-4505-13-8.
一项系统评价强调了癌症试验参与障碍研究中有效性面临的威胁。
J Clin Epidemiol. 2007 Oct;60(10):990-1001. doi: 10.1016/j.jclinepi.2006.12.013. Epub 2007 Jul 16.
4
Survey among 78 studies showed that Lasagna's law holds in Dutch primary care research.对78项研究的调查表明,拉萨尼亚法则在荷兰初级保健研究中成立。
J Clin Epidemiol. 2007 Aug;60(8):819-24. doi: 10.1016/j.jclinepi.2006.11.010. Epub 2007 Mar 26.
5
Incentives and disincentives to participation by clinicians in randomised controlled trials.临床医生参与随机对照试验的激励因素和阻碍因素。
Cochrane Database Syst Rev. 2007 Apr 18;2007(2):MR000021. doi: 10.1002/14651858.MR000021.pub3.
6
Need for high-quality studies in health technology assessments: the case of a systematic review of treatment for retinoblastoma.
Int J Technol Assess Health Care. 2006 Fall;22(4):408-18. doi: 10.1017/S0266462306051324.
7
A systematic review of reasons for nonentry of eligible patients into surgical randomized controlled trials.关于符合条件的患者未纳入外科随机对照试验原因的系统评价。
Surgery. 2006 Apr;139(4):469-83. doi: 10.1016/j.surg.2005.08.014.
8
Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors.参与癌症临床试验的障碍:对患者报告因素的荟萃分析和系统评价
Lancet Oncol. 2006 Feb;7(2):141-8. doi: 10.1016/S1470-2045(06)70576-9.
9
Barriers to participation in HIV drug trials: a systematic review.参与艾滋病药物试验的障碍:一项系统综述
Lancet Infect Dis. 2006 Jan;6(1):32-8. doi: 10.1016/S1473-3099(05)70324-8.
10
Lay public's understanding of equipoise and randomisation in randomised controlled trials.公众对随机对照试验中均衡性和随机化的理解。
Health Technol Assess. 2005 Mar;9(8):1-192, iii-iv. doi: 10.3310/hta9080.